Newsroom
All news stories Latest news
- Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets Press Release, Business Development 12 Februar 2024 Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets
- Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology to the Middle East and North Africa Press Release, Business Development 08 Januar 2024 Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology to the Middle East and North Africa
- Hikma launches authorized generic of Xyrem® (sodium oxybate) in the US Press Release, Product 03 Januar 2023 Hikma launches authorized generic of Xyrem® (sodium oxybate) in the US
- Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region Press Release, Corporate 03 Januar 2023 Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region